
Aries Agro Analyst Review 2027: Record Kharif Quarter With Profit Up 27% Near a 52-Week High
Updated: 20 Nov 2026 • 9:53 am
Posted by:

Aries Agro Stock Snapshot (19 Nov 2026)
- Current Market Price (CMP): ₹527.35
- 52-Week High / Low: ₹563.95 / ₹285.35
- Market Capitalisation: ₹685 crore
- P/E Ratio vs Industry P/E: 13.0 vs 24.7
- Latest Quarter (Q2 FY27) Revenue: ₹246.96 crore
- Latest Quarter (Q2 FY27) Net Profit: ₹25.34 crore
Quick Answer: The Aries Agro analyst review 2027 finds no named brokerage coverage as of November 2026. Q2 FY27 revenue rose 20.9% to ₹246.96 crore and net profit rose 27.2% to ₹25.34 crore, the highest quarterly profit in the last five quarters. The stock closed at ₹527.35 on 19 November 2026, about 6% below its 52-week high and about 13 times trailing earnings, so any Aries Agro share price target 2027 view depends on farm demand and seasonal swings.
The Aries Agro analyst review 2027 covers a Mumbai-based maker of specialty plant nutrients, including chelated micronutrients and water-soluble fertilisers that help crops absorb trace elements such as zinc, iron and boron. Readers searching for an Aries Agro share price target 2027 will not find a named brokerage figure, so results and valuation guide this review.
Aries Agro closed at ₹527.35 on 19 November 2026, about 6% below its 52-week high of ₹563.95 and about 85% above its low of ₹285.35. The stock has rallied hard, and this Aries Agro analyst review 2027 explains what drove the quarter and the Aries Agro stock outlook 2027.
Click Here – Get Free Investment Predictions
What Analysts Say in the Aries Agro Analyst Review 2027
| Brokerage | Rating | Target Price | Date |
|---|---|---|---|
| No verified coverage | Not available | Not available | As of November 2026 |
No named brokerage covers Aries Agro. With a market value of about ₹685 crore and institutions holding about 3.5%, it attracts little formal research.
The company's annual profit trend and seasonal pattern are the main reference points. This Aries Agro analyst review 2027 looks at both to judge the stock's rally.
Q2 FY27 Results in the Aries Agro Analyst Review 2027
| Metric | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | ₹246.96 crore | ₹204.32 crore | Up 20.9% |
| EBITDA | ₹41.16 crore | ₹38.16 crore | Up 7.9% |
| EBITDA margin | About 16.7% | About 18.7% | Down about 200 bps |
| Net profit | ₹25.34 crore | ₹19.92 crore | Up 27.2% |
| H1 FY27 net profit | ₹40.19 crore | Not compared | Close to FY26 total |
The September quarter covers the main kharif crop season, when farmers apply most of their fertilisers, so it is usually Aries Agro's strongest period. Revenue grew about 21%, while EBITDA margin narrowed by about two percentage points.
Net profit grew faster than EBITDA, helped by lower interest or other costs. In this Aries Agro analyst review 2027, first-half profit of ₹40.19 crore is already close to the full FY26 profit of ₹42.4 crore.
How Aries Agro Makes Money
Aries Agro sells crop nutrition products to farmers through a network of dealers across India.
- Chelated micronutrients: zinc, iron and other trace elements in forms plants absorb easily.
- Water-soluble fertilisers: nutrients applied through drip irrigation or sprays.
- Secondary nutrients: products such as sulphur and calcium blends.
- Dealer network: distribution to farmers in many states.
FY26 revenue rose to ₹752.8 crore from ₹627.1 crore, and net profit rose to ₹42.4 crore from ₹33.5 crore, after ₹18.4 crore in FY24. Those numbers frame this Aries Agro analyst review 2027, since profit has more than doubled in two years.
Indian soils are widely deficient in micronutrients such as zinc and boron, and government programmes promoting soil health cards and balanced fertiliser use support demand for these products. Specialty nutrients also earn better margins than bulk fertilisers such as urea, which are heavily price-controlled.
The business is seasonal. Aries Agro posted a loss of ₹4.79 crore in the March 2026 quarter, a slow period for crop inputs, after strong kharif and rabi quarters. Monsoon quality and crop prices drive farmer spending, so a weak monsoon can hurt the whole year. Unlike large, diversified companies in the Nifty 50, Aries Agro's earnings depend almost entirely on farm demand.
Operating cash flow was healthy at about ₹86 crore in FY26, and debt to equity is a low 0.15, which gives the company room to manage the working capital swings that come with seasonal sales and dealer credit.
Working capital is the swing factor in a strong season. Dealers often buy on credit before the crop season, so receivables can rise sharply when sales jump, as sales did in Q2. How quickly the company collects that money in the following quarters will decide whether the strong profit turns into cash.
Growth Triggers in the Aries Agro Analyst Review 2027
- Profit growth: Q2 profit up 27.2% to ₹25.34 crore.
- Soil health push: government focus on micronutrient use.
- Specialty margins: better pricing than bulk fertilisers.
- Cash flow: about ₹86 crore of operating cash in FY26.
- Low valuation: about 13 times earnings, central to any Aries Agro share price target 2027 view.
Key Risks in the Aries Agro Analyst Review 2027
- Monsoon dependence: weak rains cut fertiliser demand.
- Seasonality: the March quarter can show losses.
- Margin pressure: EBITDA margin slipped about 200 bps in Q2.
- Dealer credit: receivables can rise in strong seasons.
- Sharp rally: the stock is up about 85% from its low, a key point in the Aries Agro analyst review 2027.
Compare Aries Agro With Other Agro Chemical Stocks on the Univest Screener
Aries Agro Analyst Review 2027: Stock at a Glance
| Metric | Value |
|---|---|
| Share Price (19 Nov 2026) | ₹527.35 |
| 52-Week High / Low | ₹563.95 / ₹285.35 |
| Market Capitalisation | About ₹685 crore |
| P/E (TTM) | About 13.0 |
| Industry P/E | About 24.7 |
| Price to Book | About 1.83 |
| Return on Equity | About 14.1% |
| Debt to Equity | 0.15 |
| FY26 Revenue / Net Profit | ₹752.8 crore / ₹42.4 crore |
The P/E of about 13 is roughly half the industry level of about 25, even after the rally. In this Aries Agro analyst review 2027, the discount reflects the company's small size, seasonality and dependence on the monsoon.
Shareholding Trend
| Holder | Sep 2025 | Sep 2026 | Change |
|---|---|---|---|
| Promoters | 52.66% | 52.66% | No change |
| Foreign Investors (FII) | 3.20% | 2.49% | Down 0.71 points |
| Domestic Institutions (DII) | 0.00% | 0.97% | Up 0.97 points |
| Public | 44.14% | 43.88% | Flat |
Rahul Mirchandani holds 28.67% and Jimmy Mirchandani 20.18%, and the overall promoter stake did not change. Domestic institutions took a small first position while foreign holders trimmed, a mixed signal in the Aries Agro analyst review 2027.
What to Watch After the Aries Agro Analyst Review 2027
- Rabi season: December quarter sales and margins.
- Monsoon outlook: rainfall forecasts for the next kharif.
- Margins: EBITDA margin back towards 18%.
- Receivables: dealer credit after a strong season.
- Coverage: any research that sets an Aries Agro share price target 2027.
Final Word on the Aries Agro Analyst Review 2027
The Aries Agro analyst review 2027 shows strong kharif results, profit more than doubling over two years and a low valuation, balanced against seasonality, monsoon risk and a sharp share price rally.
The Aries Agro stock outlook 2027 depends on farm demand and margins. Univest does not give a buy or sell call.
Disclaimer: This article is for educational and informational purposes only and is not investment advice or a recommendation to buy, sell or hold any security. Brokerage ratings and target prices quoted here are opinions of third-party research houses; Univest does not endorse them and gives no buy or sell call. Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions
What does the Aries Agro analyst review 2027 show?
It shows a strong kharif quarter. Q2 FY27 revenue rose 20.9% to ₹246.96 crore and net profit rose 27.2% to ₹25.34 crore. EBITDA rose 7.9% to ₹41.16 crore.
Is there an Aries Agro share price target 2027 from brokerages?
No named brokerage target exists as of November 2026. The stock closed at ₹527.35 on 19 November 2026, about 6% below its 52-week high of ₹563.95. Results and valuation are the main reference points.
What does Aries Agro make?
Aries Agro makes specialty plant nutrients such as chelated micronutrients and water-soluble fertilisers. These help crops absorb zinc, iron, boron and other trace elements. It sells through dealers to farmers across India.
Why does Aries Agro report losses in some quarters?
Fertiliser demand is seasonal and peaks in the kharif and rabi crop seasons. The March quarter is usually slow, and Aries Agro lost ₹4.79 crore in the March 2026 quarter. Full-year profit was still ₹42.4 crore in FY26.
Is Aries Agro stock undervalued based on the Aries Agro analyst review 2027?
The stock trades at about 13 times earnings, roughly half the industry P/E of about 24.7. Return on equity is about 14.1% and debt to equity 0.15. The discount reflects seasonality and monsoon dependence.
What risks does the Aries Agro analyst review 2027 highlight?
The main risks are weak monsoons, seasonal losses and margin pressure. Dealer credit can raise receivables in strong seasons. The stock has also rallied about 85% from its 52-week low.
What should investors track after the Aries Agro analyst review 2027?
Track rabi season sales in the December quarter and the monsoon outlook for next year. Watch whether EBITDA margin recovers towards 18%. Receivables and any new research coverage also matter.
Recent Articles

Apex Frozen Foods Analyst Review 2027: Sales Up 15% but Q2 Profit Drops 82%
19 November 2026

Anjani Portland Cement Analyst Review 2027: Losses Narrow but the Turnaround Is Still Pending
19 November 2026

Anuh Pharma Analyst Review 2027: Profit Up 47% on Flat Sales and a Near Debt-Free Book
19 November 2026

Anik Industries Analyst Review 2027: Revenue Halves and a Small Loss at 0.28x Book
19 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Apex Frozen Foods Analyst Review 2027: Sales Up 15% but Q2 Profit Drops 82%
Anjani Portland Cement Analyst Review 2027: Losses Narrow but the Turnaround Is Still Pending
Anuh Pharma Analyst Review 2027: Profit Up 47% on Flat Sales and a Near Debt-Free Book
Anik Industries Analyst Review 2027: Revenue Halves and a Small Loss at 0.28x Book
AMJ Land Analyst Review 2027: Revenue Up 32% for a Debt-Free Pune Land Owner

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





